Immunoreactivity of Sera From Low to Moderate Malaria-Endemic Areas Against Plasmodium vivax rPvs48/45 Proteins Produced in Escherichia coli and Chinese Hamster Ovary Systems
Adult
Male
Adolescent
Endemic Diseases
gametocytes
Immunology
malaria
Antibodies, Protozoan
Antigens, Protozoan
CHO Cells
Colombia
03 medical and health sciences
[SDV.IMM.VAC] Life Sciences [q-bio]/Immunology/Vaccinology
Cricetulus
0302 clinical medicine
[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
Antibody Specificity
Escherichia coli
Malaria, Vivax
Animals
Humans
[SDV.MP.PAR]Life Sciences [q-bio]/Microbiology and Parasitology/Parasitology
Child
Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antibodies, Protozoan/blood; Antibody Specificity; Antigens, Protozoan/genetics; Antigens, Protozoan/immunology; Antigens, Protozoan/metabolism; CHO Cells; Child; Colombia/epidemiology; Cricetulus; Endemic Diseases; Escherichia coli/genetics; Escherichia coli/metabolism; Female; Guatemala/epidemiology; Humans; Immunoglobulin G/blood; Malaria, Vivax/blood; Malaria, Vivax/diagnosis; Malaria, Vivax/epidemiology; Malaria, Vivax/immunology; Male; Middle Aged; Plasmodium vivax/immunology; Plasmodium vivax/pathogenicity; Predictive Value of Tests; Recombinant Proteins/immunology; Recombinant Proteins/metabolism; Seroepidemiologic Studies; Serologic Tests; Young Adult; Plasmodium vivax; Pvs48/45; gametocytes; malaria; transmission blocking; vaccines
Aged
Aged, 80 and over
Pvs48/45
RC581-607
vaccines
Guatemala
Malaria
3. Good health
Immunoglobulin G
[SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases
transmission blocking
Female
[SDV.IMM.VAC]Life Sciences [q-bio]/Immunology/Vaccinology
Immunologic diseases. Allergy
Plasmodium vivax
[SDV.MP.PAR] Life Sciences [q-bio]/Microbiology and Parasitology/Parasitology
DOI:
10.3389/fimmu.2021.634738
Publication Date:
2021-06-24T05:24:07Z
AUTHORS (12)
ABSTRACT
P48/45 is a conserved gametocyte antigen involved in Plasmodium parasite fertilization. A recombinant Plasmodium vivax P48/45 (Pvs48/45) protein expressed in Escherichia coli (E. coli) was highly antigenic and immunogenic in experimental animals and elicited specific transmission-blocking (TB) antibodies in a previous pilot study. Here, a similar Pvs48/45 gene was expressed in Chinese Hamster Ovary (CHO) cells and we compared its immunoreactivity with the E. coli product. Specific antibody titers were determined using plasma from Colombian individuals (n=227) living in endemic areas where both P. vivax and P. falciparum are prevalent and from Guatemala (n=54) where P. vivax is highly prevalent. In Colombia, plasma seroprevalence to CHO-rPvs48/45 protein was 46.3%, while for E. coli-rPvs48/45 protein was 36.1% (p<0.001). In Guatemala, the sero prevalence was 24.1% and 14.8% (p<0.001), respectively. Reactivity index (RI) against both proteins showed an age-dependent increase. IgG2 was the predominant subclass and the antibody avidity index evaluated by ELISA ranged between 4-6 mol/L. Ex vivo P. vivax mosquito direct membrane feeding assays (DMFA) performed in presence of study plasmas, displayed significant parasite transmission-blocking (TB), however, there was no direct correlation between antibody titers and oocysts transmission reduction activity (%TRA). Nevertheless, DMFA with CHO rPvs48/45 affinity purified IgG showed a dose response; 90.2% TRA at 100 μg/mL and 71.8% inhibition at 10 μg/mL. In conclusion, the CHO-rPvs48/45 protein was more immunoreactive in most of the malaria endemic places studied, and CHO-rPvs48/45 specific IgG showed functional activity, supporting further testing of the protein vaccine potential.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (43)
CITATIONS (7)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....